NuVasive Aktie Analyse
| 08.02.19 | NuVasive Hold | Needham & Company, LLC | |
| 31.10.18 | NuVasive Buy | Needham & Company, LLC | |
| 17.10.18 | NuVasive Buy | Needham & Company, LLC | |
| 27.09.18 | NuVasive Outperform | Robert W. Baird & Co. Incorporated | |
| 01.08.18 | NuVasive Buy | Needham & Company, LLC | |
| 01.06.18 | NuVasive Neutral | Cantor Fitzgerald | |
| 04.05.18 | NuVasive Market Perform | BMO Capital Markets | |
| 02.05.18 | NuVasive Buy | Needham & Company, LLC | |
|
Werbung
|
|||
| 27.02.18 | NuVasive Buy | Needham & Company, LLC | |
| 04.01.18 | NuVasive Buy | Needham & Company, LLC | |
| 10.11.17 | NuVasive Outperform | RBC Capital Markets | |
| 25.10.17 | NuVasive Buy | Canaccord Adams | |
| 07.09.17 | NuVasive Buy | BTIG Research | |
| 28.08.17 | NuVasive Underperform | Needham & Company, LLC | |
| 28.07.17 | NuVasive Neutral | Robert W. Baird & Co. Incorporated | |
| 06.06.17 | NuVasive Outperform | RBC Capital Markets | |
| 27.05.16 | NuVasive overweight | Barclays Capital | |
| 09.10.15 | NuVasive Outperform | BMO Capital Markets | |
| 06.10.15 | NuVasive Buy | Canaccord Adams | |
| 29.07.15 | NuVasive Equal weight | Barclays Capital | |
| 29.07.15 | NuVasive Outperform | Northland Capital | |
| 14.05.15 | NuVasive Market Perform | Northland Capital | |
| 15.04.15 | NuVasive Hold | Canaccord Adams | |
| 25.02.15 | NuVasive Buy | Brean Capital | |
| 13.01.15 | NuVasive Buy | WallachBeth | |
| 08.01.15 | NuVasive Outperform | RBC Capital Markets | |
| 04.12.14 | NuVasive Buy | Brean Capital | |
| 30.09.14 | NuVasive Buy | Brean Capital | |
| 15.11.12 | NuVasive underperform | RBC Capital Markets | |
| 02.11.12 | NuVasive underperform | RBC Capital Markets | |
| 05.10.12 | NuVasive underperform | RBC Capital Markets | |
| 30.07.12 | NuVasive outperform | Barrington Research | |
| 24.07.12 | NuVasive outperform | RBC Capital Markets | |
| 09.05.12 | NuVasive overweight | Barclays Capital | |
| 03.05.12 | NuVasive sector perform | RBC Capital Markets | |
| 02.05.12 | NuVasive overweight | Barclays Capital | |
| 01.03.12 | NuVasive outperform | Barrington Research | |
| 24.02.12 | NuVasive sector perform | RBC Capital Markets | |
| 24.02.12 | NuVasive overweight | Barclays Capital | |
| 13.02.12 | NuVasive neutral | Robert W. Baird & Co. Incorporated | |
| 27.01.12 | NuVasive overweight | Barclays Capital | |
| 26.01.12 | NuVasive sector perform | RBC Capital Markets | |
| 18.01.12 | NuVasive overweight | Barclays Capital | |
| 03.01.12 | NuVasive hold | Kaufman Bros., LP | |
| 31.10.11 | NuVasive overweight | Barclays Capital | |
| 03.10.11 | NuVasive outperform | Barrington Research | |
| 30.09.11 | NuVasive sector perform | RBC Capital Markets | |
| 27.09.11 | NuVasive sector perform | RBC Capital Markets | |
| 26.09.11 | NuVasive overweight | Barclays Capital | |
| 22.09.11 | NuVasive hold | Kaufman Bros., LP | |